Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome

Tasaki Shinya; Suzuki Katsuya; Nishikawa Ayumi; Kassai Yoshiaki; Takiguchi Maiko; Kurisu Rina; Okuzono Yuumi; Miyazaki Takahiro; Takeshita Masaru; Yoshimoto Keiko; Yasuoka Hidekata; Yamaoka Kunihiro; Ikeura Kazuhiro; Tsunoda Kazuyuki; Morita Rimpei; Yoshimura Akihiko; Toyoshiba Hiroyoshi; Takeuchi Tsutomu

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome

【24h】

Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome

机译：多种疾病签名在原发性Sjogren综合征中收敛到细胞毒性CD8 T细胞

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives Multiomics study was conducted to elucidate the crucial molecular mechanisms of primary Sjogren's syndrome (SS) pathology.

机译：None

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2017年第8期|共9页
作者
Tasaki Shinya; Suzuki Katsuya; Nishikawa Ayumi; Kassai Yoshiaki; Takiguchi Maiko; Kurisu Rina; Okuzono Yuumi; Miyazaki Takahiro; Takeshita Masaru; Yoshimoto Keiko; Yasuoka Hidekata; Yamaoka Kunihiro; Ikeura Kazuhiro; Tsunoda Kazuyuki; Morita Rimpei; Yoshimura Akihiko; Toyoshiba Hiroyoshi; Takeuchi Tsutomu;
展开▼
作者单位

Takeda Pharmaceut Co Ltd Integrated Technol Res Labs Div Pharmaceut Res Fujisawa Kanagawa;

Keio Univ Sch Med Dept Internal Med Div Rheumatol Shinjyu Ku Shinanomachi 35 Tokyo 1608582;

Keio Univ Sch Med Dept Internal Med Div Rheumatol Shinjyu Ku Shinanomachi 35 Tokyo 1608582;

Takeda Pharmaceut Co Ltd Div Pharmaceut Res Immunol Unit Fujisawa Kanagawa Japan;

Takeda Pharmaceut Co Ltd Div Pharmaceut Res Immunol Unit Fujisawa Kanagawa Japan;

Takeda Pharmaceut Co Ltd Div Pharmaceut Res Immunol Unit Fujisawa Kanagawa Japan;

Takeda Pharmaceut Co Ltd Div Pharmaceut Res Immunol Unit Fujisawa Kanagawa Japan;

Takeda Pharmaceut Co Ltd Div Pharmaceut Res Immunol Unit Fujisawa Kanagawa Japan;

Keio Univ Sch Med Dept Internal Med Div Rheumatol Shinjyu Ku Shinanomachi 35 Tokyo 1608582;

Keio Univ Sch Med Dept Internal Med Div Rheumatol Shinjyu Ku Shinanomachi 35 Tokyo 1608582;

Keio Univ Sch Med Dept Internal Med Div Rheumatol Shinjyu Ku Shinanomachi 35 Tokyo 1608582;

Keio Univ Sch Med Dept Internal Med Div Rheumatol Shinjyu Ku Shinanomachi 35 Tokyo 1608582;

Keio Univ Sch Med Dept Dent &

Oral Surg Shinjuku Ku Tokyo Japan;

Keio Univ Sch Med Dept Dent &

Oral Surg Shinjuku Ku Tokyo Japan;

Keio Univ Sch Med Dept Microbiol &

Immunol Shinjuku Ku Tokyo Japan;

Keio Univ Sch Med Dept Microbiol &

Immunol Shinjuku Ku Tokyo Japan;

Takeda Pharmaceut Co Ltd Integrated Technol Res Labs Div Pharmaceut Res Fujisawa Kanagawa;

Keio Univ Sch Med Dept Internal Med Div Rheumatol Shinjyu Ku Shinanomachi 35 Tokyo 1608582;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Characteristics of parotid gland ultrasonography in patients with primary Sjogren’s syndrome and its value to judge the severity of disease [J] . Lan Tian, Jing Yang, Yu Zhang, 海南医科大学学报（英文版） . 2016,第005期
2. Genome-wide DNA methylation patterns in monocytes derived from patients with primary Sjogren syndrome [J] . Xuan Luo, Wen Zhang, Yu Peng, 中华医学杂志（英文版） . 2021,第011期
3. Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome [J] . Tasaki Shinya, Suzuki Katsuya, Nishikawa Ayumi, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2017,第8期

机译：多种疾病签名在原发性Sjogren综合征中收敛到细胞毒性CD8 T细胞
4. Imbalance in subsets of circulating innate lymphoid cells is associated with disease activity and type i interferon signature in primary Sjogren's syndrome [J] . Blokland S. L. M., van den Hoogen L. L., Leijten E. F. A., Clinical and experimental rheumatology . 2018,第3Suppla112期

机译：循环先天淋巴细胞的亚群中的不平衡与疾病活性和原发性Sjogren综合征中的I型干扰素签名有关
5. Imbalance in subsets of circulating innate lymphoid cells is associated with disease activity and type i interferon signature in primary Sjogren's syndrome [J] . Blokland S. L. M., van den Hoogen L. L., Leijten E. F. A., Clinical and experimental rheumatology . 2018,第3Suppla112期

机译：循环先天淋巴细胞的亚群中的不平衡与疾病活性和原发性Sjogren综合征中的I型干扰素签名有关
6. Towards the establishment of a biomedical ontology for the primary Sjogren's Syndrome [C] . Vasileios C. Pezoulas, Themis P. Exarchos, Vassiliki Andronikou, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018

机译：建立原发性Sjogren综合征的生物医学本体论
7. Supercharged Natural Killer Cells Preferentially Expand CD8 + Cytotoxic T Cells While Targeting CD4+ Helper T Cells [D] . Ohanian, Narek. 2017

机译：增压的自然杀伤细胞可优先扩增CD8 +细胞毒性T细胞，同时靶向CD4 +辅助T细胞
8. Extended report: Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren’s syndrome [O] . Shinya Tasaki, Katsuya Suzuki, Ayumi Nishikawa, -1

机译：扩展报告：多发性疾病特征聚集到原发性干燥综合征中的细胞毒性CD8 T细胞上
9. Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren’s syndrome [O] . Shinya Tasaki, Katsuya Suzuki, Ayumi Nishikawa, 2017

机译：多种疾病签名在原代Sjögren综合征中收敛到细胞毒性CD8 T细胞
10. Mechanisms of Transendothelial Migration of Primary Human Invasive Ductal Carcinoma Cells from ER , Her2 , and Triple Negative Disease. [R] . Pignatelli, J. 2016

机译：ER，Her2和三重阴性疾病的原发性人类浸润性导管癌细胞跨内皮迁移机制。

Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjogren's syndrome

摘要

著录项

相似文献

相关主题

期刊订阅